|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01652 FUSEN PHARM
Nominal 
0.920 +0.010 (+1.099%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (73,334) | 110,490 | 47,766 | 153,207 |
| Net Cash from / (used in) Investing Activities | -- | (108,318) | (13,131) | (282,977) | (68,197) |
| Net Cash from / (used in) Financing Activities | -- | 88,503 | (51,766) | 20,527 | (116,330) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (93,149) | 45,593 | (214,684) | (31,320) |
| Cash & Cash Equivalents at beginning of period | -- | 128,106 | 81,063 | 297,038 | 331,044 |
| Effect of Foreign Exchange Rate Changes | -- | (108) | 1,450 | (1,291) | (2,686) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 34,849 | 128,106 | 81,063 | 297,038 |
| Remarks: | Real time quote last updated: 28/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -36,941,000 |
| %Change | -- |
| EPS / (LPS) | RMB -0.050 |
| NBV Per Share (¥) | RMB 0.694 |